Genomic and expression analysis of the vanG-like gene cluster of Clostridium difficile

Distribution of the vanG-like gene cluster in Clostridium difficile clinical isolates

(2012) Fariza Ammam et al.   CANADIAN JOURNAL OF MICROBIOLOGY

Clostridium difficile

(2012) Sarah Tschudin-Sutter et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Structural and Functional Characterization of VanG d-Ala:d-Ser Ligase Associated with Vancomycin Resistance inEnterococcus faecalis

(2012) Djalal Meziane-Cherif et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

d-Ala-d-Ser VanN-Type Transferable Vancomycin Resistance in Enterococcus faecium

(2011) François Lebreton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clostridium difficileHas an Original Peptidoglycan Structure with a High Level ofN-Acetylglucosamine Deacetylation and Mainly 3-3 Cross-links

(2011) Johann Peltier et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

vanM, a New Glycopeptide Resistance Gene Cluster Found in Enterococcus faecium

(2010) X. Xu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The β-lactam-sensitived,d-carboxypeptidase activity of Pbp4 controls thel,dandd,dtranspeptidation pathways inCorynebacterium jeikeium

(2009) Marie Lavollay et al.   MOLECULAR MICROBIOLOGY

Activation of the l,d-transpeptidation peptidoglycan cross-linking pathway by a metallo-d,d-carboxypeptidase inEnterococcus faecium

(2009) Emmanuelle Sacco et al.   MOLECULAR MICROBIOLOGY

Molecular Characterization of Enterococcus faecalis N06-0364 with Low-Level Vancomycin Resistance Harboring a Novel D-Ala-D-Ser Gene Cluster, vanL

(2008) D. A. Boyd et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment ofClostridium difficileInfection

(2008) Dale N. Gerding et al.   CLINICAL INFECTIOUS DISEASES